|本期目录/Table of Contents|

[1]邹大威,高彦彬,李娇阳,等.糖肾宁对糖尿病肾病大鼠肾组织nephrin、desmin表达的影响[J].环球中医药,2015,8(03):307-312.[doi:10.3969/j.issn.1674-1749.2015.03.011]
　ZOU Da-wei,GAO Yan-bin,Li Jiao-yang,et al.Effects of Tangshenning on nephrin, desmin expression of renal tissue in STZ-Induced diabetic rats[J].,2015,8(03):307-312.[doi:10.3969/j.issn.1674-1749.2015.03.011]
点击复制

糖肾宁对糖尿病肾病大鼠肾组织nephrin、desmin表达的影响()
     
分享到：

《环球中医药》[ISSN:1006-6977/CN:61-1281/TN]

卷:
第8卷
期数:
2015年03期
页码:
307-312
栏目:
论著
出版日期:
2015-03-06

文章信息/Info

Title:
Effects of Tangshenning on nephrin, desmin expression of renal tissue in STZ-Induced diabetic rats
作者:
邹大威; 高彦彬; 李娇阳; 周盛楠; 王馨瑶; 龚慕辛; 耿建国; 王金羊; 朱智耀; 张娜
100069 首都医科大学中医药学院[邹大威、高彦彬、李娇阳(硕士研究生)、周盛楠(硕士研究生)、王馨瑶(硕士研究生)、龚慕辛、耿建国、王金羊(博士研究生)、朱智耀、张娜(博士研究生)]; 中医络病研究北京市重点实验室[邹大威、高彦彬、李娇阳(硕士研究生)、周盛楠(硕士研究生)、王馨瑶(硕士研究生)、龚慕辛、耿建国、王金羊(博士研究生)、朱智耀、张娜(博士研究生)]
Author(s):
ZOU Da-wei;  GAO Yan-bin;  Li Jiao-yang;  et al.
School of Traditional Chinese Medicine, Capital Medical University,Beijing 100069, China Corresponding author:GAO Yan-bin,E-mail:dfyynfm@163.com
关键词:
糖尿病肾病;  足细胞损伤;  糖肾宁
Keywords:
Diabetic nephropathy;  Tangshenning;  Podocyte injury
分类号:
R285.5
DOI:
10.3969/j.issn.1674-1749.2015.03.011
文献标志码:
A
摘要:
目的 探讨糖肾宁对链脲佐菌素诱导的糖尿病大鼠肾小球足细胞损伤的影响。方法 8周龄SPF级雄性SD大鼠46只,随机选择10只为对照组,其余大鼠予大剂量STZ腹腔注射建立糖尿病模型。其中34只大鼠血糖≥16.7 mmol/L视为糖尿病模型建立成功,随机分为模型组、缬沙坦组、糖肾宁组,予糖肾宁及缬沙坦干预12周,测定空腹血糖、血清尿素氮、血清肌酐、24小时尿蛋白,足细胞裂孔隔膜蛋白nephrin、骨架蛋白desmin的蛋白或基因表达。结果 与对照组比较,模型组大鼠空腹血糖、血清尿素氮、血清肌酐、24小时尿蛋白均明显升高(P<0.05),desmin蛋白、基因表达上调(P<0.05)、nephrin mRNA表达下调(P<0.05); 与模型组比较,糖肾宁、缬沙坦干预后, desmin蛋白、基因表达下调(P<0.05)、nephrin mRNA表达上调(P<0.05),血清尿素氮、血清肌酐、24小时尿蛋白显著降低(P<0.05),但血糖无明显变化 。结论 糖肾宁干预链脲佐菌素诱导的糖尿病肾病大鼠可减少肾小球足细胞损伤,降低蛋白尿、保护肾功能。
Abstract:
Objective Objective To investigate the effects of Tangshenning on podocyte injury of renal tissue in streptozotocin(STZ)induced diabetic rats. Methods: Non-diabetic rats(n=10)were designed as the control group, other rats were given STZ to induce diabetic model. The diabetic rats(fasting blood glucose≥16.7mmol /L)were randomly divided into three groups: the model group(n=12), the Tangshenning group(n=11)and the Valsartan group(n=11), After intervention with Tangshenning and valsartan for 12 weeks, 24h Urinary protein excretion(24h UPro), fasting blood glucose(FBG), serum creatinine(Scr), serum urea nitrogen(BUN)were examined. The protein and mRNA expression of podocyte slit diaphragm protein nephrin and cytoskeletal protein desmin mRNA expression were accessed. Results FBG, BUN, SCr, 24h UPro as well as desmin protein and mRNA expression of renal tissue in model group were increased significantly(P<0.05), nephrin mRNA expression of renal tissue in model group were decreased significantly(P<0.05)compared with non-diabetic rats group. Obviously, after Tangshenning or Valsartan intervention, 24h UPro, BUN and SCr were significantly declined(P<0.05), while no significant change of FBG after intervention(P>0.05).Tangshenning or valsartan could also decrease desmin expression and increase nephrin expression compared with model group. Conclusion Tangshenning could alleviate podocyte injury of renal tissue in STZ-induced diabetic rats, as well as reducing proteinuria and protecting renal function.

参考文献/References:

[1] Y Xu, L Wang, J He et al. Prevalence and Control of Diabetes in Chinese Adults [J]. JAMA,2013,310(9):948-958.
[2] Lea J, Pnicholas SB. Diabetes mellitus and hypertension: Key risk factors for kidney disease[J].J Natl Med Assoc,2008, 94(Suppl 8):7-15.
[3] Dalla VestraM, MasieroA, RoiterAM, et al.Is podocyte injury relevant in diabetic nephro-pathy? Studies in patients with type 2 diabetes[J].Diabetes, 2003,52(4):1031-1035.
[4] 杨倩,梁伟,丁国华.足细胞损伤与糖尿病肾病[J].中国医学前沿杂志,2012, 4(9):10-13.
[5] Ziyadeh F N,Wolf G. Pathogenesis of the podocytopathy and proteinuria in diabetic glo-merulopathy[J].Curr Diabetes Rec,2008,4(1):39- 45.
[6] 高彦彬,赵慧玲,周晖,等.糖肾宁治疗气阴两虚、络脉瘀滞型早期糖尿病肾病临床研究[J].中华中医药杂志,2006,21(7):409- 411.
[7] 徐丽华,刘春雷,常玉梅,等.双标准曲线相对定量PCR试验原理与方法[J].生物技术通报,2011,(1):70-75.
[8] 杨亦彬, 张翥, 苏克亮, 等. 链脲佐菌素诱导大鼠糖尿病肾病模型的方法学探讨[J]. 华西医学, 2005,(2): 299-300.
[9] 刘晓, 高媛媛, 鲁茜,等. 银杏叶提取物、卡托普利和缬沙坦对大鼠糖尿病肾病保护作用的比较[J]. 中药材, 2008,(1): 97-100.
[10] 李秋月,李六生,李桂霞,等.坎地沙坦对糖尿病肾病大鼠足细胞Nephrin、Podocin和CD2AP表达的影响[J].华中科技大学学报(医学版),2012,41(3):310-313.
[11] 黄平,王雁秋.绞股蓝总皂苷对糖尿病肾病大鼠足细胞损伤的影响及机制[J].中华中医药杂志,2012,27(3):723-726.
[12] M. Kestila, U. Lenkkeri and M. Mannikko, et al., Positionally cloned gene for a novel glomerular protein—nephrin—is mutated in congenital nephrotic syndrome [J]. Molecular Cell,1998, 1(4): 575-582.
[13] 石绮屏. Nephrin基因表达的改变与糖尿病肾病[J]. 国外医学(内分泌学分册),2004,(1): 5-27.
[14] F. Bonnet, M.E. Cooper, H. Kawachi, et al., Irbesartan normalises the deficiency in glomerular nephrin expression in a model of diabetes and hypertension[J]. Diabetologia, 2001,44(7): 874- 877.
[15] 孙桂芝,孙艳艳,方敬爱.糖尿病肾病足细胞损伤的研究进展[J].中国中西医结合肾病杂志,2008,9(2):177-178.
[16] LIY, KANG Y S, DAIC, etal. Epithelial-to-mesenchymal transition is a potential pathway leading to podocyte dysfunction and proteinuria[J].Am J Pathol,2008,172(2):299-308.
[17] ZhangC,HuJJ,XiaM,et al. Protection of Podocytes from hy Perhomocysteinemia-induced injury by deletion of the gP91Phox gene[J].Free Radic Biol Med,2010,48:1109-1117.
[18] H.Y. Dai, M. Zheng, R.N. Tang, et al. Effects of angiotensin receptor blocker on phenotypic alterations of podocytes in early diabetic nephropathy[J].American Journal of the Medical Sciences,2011,341(3):207-214.

相似文献/References:

[1]刘孝琴 王云枫 李雅楠.参芪地黄汤加味配合门冬胰岛素对早期2型糖尿病肾病 负氮平衡的影响[J].环球中医药,2013,6(05):366.
[2]王涵 周强 仝小林.仝小林治疗糖尿病并发症应用黄芪经验[J].环球中医药,2013,6(04):272.
[3]李光超 车念聪 耿建国等.加味消渴康对糖尿病肾病大鼠肝组织细胞外基质相关 调节因子表达的影响[J].环球中医药,2014,7(02):88.
　LI Guang chao,CHE Nian cong,GENG Jian guo,et al.The effects of JiaweiXiaokekang on the expressions of factors regulating the hepatic extracellular matrix in DN rats[J].,2014,7(03):88.
[4]郑洪光,李秀兰,石燕萍,等.糖尿病肾病130例中医证型分类研究[J].环球中医药,2012,5(10):783.
[5]齐铮,赵进喜,王硕仁,等.糖尿病肾病中医证候分布规律的文献研究[J].环球中医药,2012,5(12):914.
　QI Zheng,ZHAO Jin-xi,WANG Shuo-ren,et al.Distribution regules on syndrone of diabetic nephropathy[J].,2012,5(03):914.
[6]周盛楠 高彦彬 李娇阳等.通心络对早期糖尿病肾病大鼠肾功能及肾组织NO/eNOS表达的影响[J].环球中医药,2014,7(11):821.
　ZHOU Sheng-nan,GAO Yan-bin,LI Jiao-yang,et al.Effects of Tong Xinluo on renal function and NO/eNOS expression in kidney in DN rats[J].,2014,7(03):821.
[7]熊燕.余江毅教授治疗糖尿病肾病经验[J].环球中医药,2015,8(04):474.[doi:10.3969/j.issn.1674-1749.2015.04.028]
[8]邹大威,高彦彬,刘迎新,等.糖肾宁对自发性2型糖尿病KKAy小鼠肾组织MMP9、TIMP1表达的影响[J].环球中医药,2015,8(11):1324.[doi:10.3969/j.issn.1674-1749.2015.11.013]
　ZOU Da wei,GAO Yan bin,LIU Ying xin,et al.Effects of Tangshenning on MMP9、TIMP1 expression of renal tissue in type 2 diabetic KKay mice[J].,2015,8(03):1324.[doi:10.3969/j.issn.1674-1749.2015.11.013]
[9]申子龙,赵进喜,王颖辉,等.基于因子分析的早期糖尿病肾病证候要素研究[J].环球中医药,2016,9(02):129.[doi:10.3969/j.issn.1674-1749.2016.02.001]
　SHEN Zi-long,ZHAO Jin-xi,WANG Ying-hui,et al.Study on the syndrome characteristics of early diabetic nephropathy based on the factor analysis[J].,2016,9(03):129.[doi:10.3969/j.issn.1674-1749.2016.02.001]
[10]贾冕,赵进喜,皇甫伟.基于中医证候学的糖尿病肾病患者肾小球滤过率评估方法的探索[J].环球中医药,2016,9(03):275.[doi:10.3969/j.issn.1674-1749.2016.03.006]
　JIA Mian,ZHAO Jin xi,HUANG Fu Wei..Exploration of GFR evaluation method in patients with diabetic nephropathy based on the theory of TCM syndrome[J].,2016,9(03):275.[doi:10.3969/j.issn.1674-1749.2016.03.006]

备注/Memo

备注/Memo:
基金项目:北京市教育委员会首都中医药研究专项面上项目(13ZY07) 作者简介:邹大威(1982- ),女,博士,讲师。研究方向:中医药防治糖尿病及其并发症研究。E-mail:5362559@qq.com 通讯作者:高彦彬(1959- ),博士,教授,博士生导师。研究方向:中医药防治糖尿病及其并发症研究。E-mail:dfyynfm@163.com
更新日期/Last Update: 2015-03-20